[{"Assets_0_Q2_USD":"905227000.0","CIK":"1743881","CommonStockSharesIssued_0_Q2_shares":"124665939.0","CommonStockSharesOutstanding_0_Q2_shares":"122251258.0","Country":"United States","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"1594164456.0","MinorityInterest_0_Q2_USD":"59847000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"-171769000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":"-121034000.0","NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":"-212884000.0","OfficialName":"BridgeBio Pharma Inc. Common Stock","ProfitLoss_1_Q2_USD":"-136214000.0","ProfitLoss_2_Q2_USD":"-240296000.0","SP500":null,"Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":"325606000.0","StockholdersEquity_0_Q2_USD":"265759000.0","Ticker":"BBIO","TreasuryStockSharesConverted_0_Q2_shares":"2414681.0","WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":"117012062.0","WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":"117407750.0","filed":"20200811","footnote":null,"form":"10-Q","fp":"Q2","fy":"2020.0","name":"BRIDGEBIO PHARMA, INC.","period":"20200630","qtrs":"0","uom":"USD"}]